The Institut Salah Azaïez in Tunis, founded in 1969, is Tunisia's national cancer institute and one of Africa's oldest; it runs the Tunis cancer registry, a contributor to IARC's Cancer Incidence in Five Continents, and researches breast cancer in young women and nasopharyngeal carcinoma.
The Institut Salah Azaïez in Tunis was founded in 1969 and named for the Tunisian surgeon who championed cancer care; it is Tunisia's national cancer institute and reference hospital, attached to the Université de Tunis El Manar faculty of medicine, providing surgical, medical and radiation oncology, brachytherapy, nuclear medicine, paediatric oncology and pathology. The institute runs the Tunis population-based cancer registry, one of the longest-running in Africa and a contributor to IARC's Cancer Incidence in Five Continents, and its research addresses breast cancer in young North African women, nasopharyngeal carcinoma and EBV, cervical cancer screening, hereditary cancer, and radiotherapy quality across the Maghreb. It trains oncologists for Tunisia and francophone Africa.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Institut Salah-Azaïz, including child institutions. 101 works · 116 citations · 57% open access · 1% clinical trials · 0% reviews.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, Head and neck squamous cell carcinoma.
Shares International Agency for Research on Cancer (IARC / WHO), Brachytherapy, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), HR-positive / HER2-negative breast cancer.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.